Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Filings indexed 649 across all filing types
Latest filing 2026-05-20 AGM Information
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
PHARMENA Projekty uchwał na ZWZ_w dniu 25 06 2026
AGM Information Classification · 87% confidence The document contains the draft resolutions (‘projekty uchwał’) to be considered and approved at the Ordinary General Meeting of PHARMENA S.A. on June 25, 2026. It lists the agenda items, approval of financial statements, discharge of board members, and other AGM resolutions. This aligns with AGM Information (materials shared during the Annual General Meeting).
2026-05-20 Polish
Pharmena_ogłoszenie o zwołaniu ZWZ_25 06 2026
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a formal announcement convening the Ordinary General Meeting (AGM) of PHARMENA S.A., including the agenda, registration date, shareholder rights, and proxy procedures. It is not the AGM presentation materials themselves (AGM-R), nor a report of results. Rather, it is the solicitation/information statement sent to shareholders to inform them of the meeting and voting procedures. This aligns with our Proxy Solicitation & Information Statement category (PSI).
2026-05-20 Polish
Zwołanie Zwyczajnego Walnego Zgromadzenia na dzień 25 czerwca 2026 r. - Content (PL)
Proxy Solicitation & Information Statement Classification · 80% confidence The document is an announcement by the Management Board of PHARMENA S.A. convening the Ordinary General Meeting on June 25, 2026, including draft resolutions and other materials for shareholder consideration and voting—which corresponds to proxy solicitation/information statement materials for an AGM. It is not a full annual report, earnings release, or voting results, but rather the official convocation and accompanying documents for the shareholder meeting.
2026-05-20 Polish
Udzielenie patentu w Kanadzie - Content (PL)
Regulatory Filings
2026-05-05 Polish
Zawarcie umowy na badania stabilności przyszłego wyrobu medycznego na trudno gojące się rany - Content (PL)
Regulatory Filings Classification · 75% confidence The document is a current update notice (“raport bieżący”) published in the ESPI system, detailing the signing of a research contract and project milestones. It is not an earnings release, quarterly/annual report, capital change, or other specific category but rather a general regulatory announcement of a material event. This fits the Regulatory Filings (RNS) category.
2026-04-13 Polish
Zakończenie opracowania i walidacji metod analizy przyszłego wyrobu medycznego na trudno gojące się rany - Content (PL)
Regulatory Filings Classification · 80% confidence The document is a ‘raport bieżący’ (current report) under the Polish ESPI system announcing the completion of a project milestone (analytical method development/validation) and future project stages. It is a corporate update on R&D progress rather than a financial results release, regulatory change, share issue, or formal report like an annual or interim report. It does not include detailed financial tables or request shareholder votes. It therefore falls into the general fallback category for miscellaneous regulatory filings (RNS).
2026-03-24 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.